Jump to any asset
849 assets, updated daily
As of October 10, 2026, Colgate-Palmolive Co. (CL) trades at $88.27. CleaRank Financial AI rates it Hold with a fair value of $88.27, in line with the current price. Wall Street's consensus target is $100.00 across 21 analysts. RSI at 60 is in neutral territory, and the price is below its 50-day average of $89.17.
Colgate-Palmolive Co. (CL)
Colgate-Palmolive Co. NYSE
$88.27
0.1700 (0.19%)
At close: Oct 9, 4:00 PM EDT
AI Analyst Consensus
55 / 100
Colgate-Palmolive Co. (CL) is currently trading at $88.27, below its 50-day and 200-day moving averages ($89.17 and $88.69), indicating near-term technical weakness. The company operates in the Consumer Defensive sector, specifically Household & Personal Products, a space generally characterized by stable demand. Despite the technical headwinds, Wall Street analysts maintain a consensus 'Buy' rating with a median price target of $100, suggesting a 13.3% upside potential. The company's fundamentals show a strong return on equity of 267.37% and a healthy profit margin of 9.68%, though its P/E ratio of 34.71 is elevated compared to sector averages. A key risk remains the significant insider selling activity, with over $57 million in sales reported, signaling potential concerns from management.
CL Price Analysis
Market Metrics
Open
$87.67
Day Range
$87.64 to $88.66
Prev Close
$88.10
Volume
3.17M
52-Week Range
$74.55 to $99.33
Market Cap
$70.37B
Peer Benchmarking
Valuation vs Sector (Consumer Defensive)
Performance vs VDC
Sector Position Analysis
Trading at a significant premium to sector peers (+43%), suggesting market expectations for superior growth or market position.
CL Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
Analysis: In the last 5 quarters, CL beat estimates 5 times. However, the stock fell 3 times the next day. This suggests positive news is often "priced in" or investors are selling the news.
CL Analysis
Company's Health
4/5
12-Month Analyst Target
+13.29% Upside
Median of 21 analysts (12-month)
$100.00
AI Technical Analysis
Colgate-Palmolive's stock is currently trading below its 50-day and 200-day moving averages ($89.17 and $88.69), suggesting a bearish short-term trend. However, the price is above its 20-day EMA ($87.07), indicating some recent buying interest. The RSI is at 59.98, in neutral territory, while the MACD is slightly negative at -0.49, pointing to a lack of strong momentum in either direction. The current price of $88.27 is hovering around the 200-day SMA. Resistance may be found near the 50-day SMA. Volume was below average on the latest trading day, suggesting caution from market participants. The overall technical picture is mixed, with the stock showing signs of weakness against longer-term averages but holding above its immediate EMA.
ProTips
- Significant insider selling totaling over $57 million warrants close monitoring as it may signal management's concerns about near-term stock performance.
- The stock is trading below its 50-day and 200-day moving averages ($89.17 and $88.69), suggesting potential for further downside if key support levels are breached.
- Consider the company's dividend yield of 2.38% as a component of total return, though growth prospects appear moderate.
Key Catalysts
Bearish
Heavy Insider Selling Pressure
Insiders have sold over $57.3 million in stock with no reported purchases, indicating a strong bearish signal from management regarding the stock's near-term prospects.
Source: Insider Trading DataNeutral
Consistent Earnings Beats
Colgate-Palmolive has a track record of beating EPS estimates, including a 4.21% surprise in the quarter to June 2026 and a significant 54.76% beat in the quarter to March 2026, demonstrating operational resilience.
Source: Earnings ReportsNeutral
Stable Revenue Growth Projections
Forward estimates indicate continued modest revenue growth of approximately 3.00% for the next quarter and next year, supporting the company's stable, defensive profile.
Source: Analyst EstimatesBullish
Wall Street Buy Consensus and Price Target
Despite insider selling, 21 Wall Street analysts maintain a consensus 'Buy' rating with a median price target of $100, suggesting a potential 13.3% upside from current levels.
Source: Wall Street AnalystsMarket Outlook
The base case scenario for Colgate-Palmolive over the next 6-12 months suggests a stable performance, with analysts projecting a median price target of $100, implying a 13.3% upside. The company's strong brand portfolio and consistent earnings performance provide a defensive foundation. However, potential catalysts for upside are limited given the current valuation and technical positioning. Downside risks include a continued trend of insider selling, a potential re-rating of the stock to align with sector valuation averages, or any unexpected slowdown in consumer spending that could impact demand for its products.
Key Statistics
| Market Cap | 70.37B |
|---|---|
| P/E Ratio | 34.71 |
| EPS (TTM) | 2.54 |
| Dividend Yield | 2.38% |
| 52 Week High | 99.33 |
| 52 Week Low | 74.55 |
Colgate-Palmolive's valuation appears stretched, with a P/E ratio of 34.71 significantly higher than the sector median of 24.2. Its price-to-sales ratio of 3.34 also exceeds the sector average of 2.2. Despite this premium valuation, the company demonstrates exceptional profitability with a return on equity of 267.37% and a net profit margin of 9.68%, far surpassing sector medians. The company's balance sheet appears strong, with a debt-to-equity ratio of 13.88%, well below the sector average. Revenue growth has been modest at 4.9%, aligning with the sector average of 5.3%. While fundamentals are strong, the current stock price does not offer significant upside based on fair value, and the high P/E ratio warrants caution.
Earnings & Growth Analysis
Colgate-Palmolive recently reported earnings for the quarter to June 2026, with an actual EPS of $0.99, beating the estimate of $0.95 by 4.21%. This followed a positive surprise in the prior quarter to March 2026, where actual EPS was $0.65 against an estimate of $0.42, a significant 54.76% beat. The company has demonstrated a pattern of meeting or exceeding earnings expectations in recent quarters, suggesting operational resilience. Forward estimates indicate continued modest growth, with the next quarter's average EPS estimate at $0.966 and next year's at $4.10. Revenue growth is projected to be around 3.00% for the next quarter and 3.00% for the next year, indicating a stable but not explosive growth trajectory.
Key Risks
The most significant risk for Colgate-Palmolive is its elevated valuation, with a P/E ratio considerably higher than its sector peers, potentially limiting upside. Also, substantial insider selling, totaling over $57 million, raises concerns about management's near-term confidence in the stock's prospects. The stock is also trading below key long-term moving averages, indicating potential technical headwinds.
Technical Indicators
| RSI (14) | 59.98 |
|---|---|
| MACD | -0.49 |
| SMA 50 | 89.17 |
| SMA 200 | 88.69 |
RSI
Neutral
SMA Cross
Neutral
Price vs SMA
Bearish
MACD
Bearish
Price is trading below the 50-day SMA.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.01
Weak correlation
Nasdaq 100 (QQQ)
-0.13
Weak correlation
Bitcoin (BTC)
-0.06
Weak correlation
Gold (XAU)
+0.04
Weak correlation
Check Custom Correlation
How does any other asset move with CL? One year of daily closes, Pearson correlation.
Try
CL Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Entry Strategies pick an entry style
Conservative
$87.39
Slight discount to current
Wait for small dip
Aggressive
$88.27
At current price
Enter now if confident
Risk Management
STOP LOSS
$84.77
MAX LOSS
-3.0%
Volatility-Adjusted Stop Loss
Calculated based on RSI (60.0) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$90.01
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$91.76
+5% (Conservative)
+4.0% (Aggressive)
TARGET 3
$94.38
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for CL is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on October 10, 2026.Growth of $10,000
A $10,000 investment in CL in October 2016 would be worth about $12,157 today, compared with about $36,018 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CL today could grow to about $15,260 by 2036 in the base case, with a bull case near $34,250 and a bear case around $6,799. Projections are statistical simulations, not guarantees.
CL Stock Price Prediction: 2030
CleaRank's simulation projects a price near $105 for CL by 2030 in the base case, from $88.27 today (1.2x over 4 years). The downside path ends near $62.69. These are outcomes of a Monte Carlo simulation run on CL's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $71.31 | $92.08 | $119 |
| 2028 | $66.91 | $96.06 | $138 |
| 2029 | $64.35 | $100 | $156 |
| 2030 | $62.69 | $105 | $174 |
| 2031 | $61.56 | $109 | $193 |
| 2032 | $60.81 | $114 | $213 |
| 2033 | $60.33 | $119 | $233 |
| 2034 | $60.06 | $124 | $255 |
| 2035 | $59.97 | $129 | $278 |
| 2036 | $60.02 | $135 | $302 |
Method: 10,000 simulated price paths using CL's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
CL Insider Trading Analysis
Bought
None
No open-market buys
Sold
$57.3M
14 Transactions
Insiders
19
Active Traders
Avg Transaction
$4.1M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | WALLACE NOEL R
Chief Executive Officer
|
Sell | 322.0K | $29.7M |
| Nov 5, 2021 | WALLACE NOEL R
Chief Executive Officer
|
Sell | 245.2K | $18.9M |
| Nov 4, 2020 | JAKOBSEN HENNING I.
Chief Financial Officer
|
Sell | 145.3K | $12.4M |
| Feb 4, 2026 | SUTULA STANLEY J III
Chief Financial Officer
|
Sell | 97.8K | $9.2M |
| Feb 20, 2024 | WALLACE NOEL R
Chief Executive Officer
|
Sell | 99.7K | $8.4M |
| Aug 5, 2020 | WALLACE NOEL R
Chief Executive Officer
|
Sell | 85.9K | $6.6M |
| Aug 12, 2020 | HUSTON JOHN J JR
Chairman of the Board
|
Sell | 84.9K | $6.6M |
| May 8, 2023 | PARAMESWARAN PRABHA
Officer
|
Sell | 64.4K | $5.2M |
| Feb 1, 2024 | DANIELS JENNIFER M
Officer
|
Sell | 61.6K | $5.2M |
| Feb 6, 2020 | MARSILI DANIEL B
Officer
|
Sell | 66.8K | $5.1M |
Page 1 of 1
Frequently Asked Questions
Is Colgate-Palmolive (CL) stock a buy right now?
Colgate-Palmolive (CL) is currently rated a 'Hold' with a consensus score of 55. While Wall Street analysts have a 'Buy' rating and a median price target of $100, suggesting potential upside, the stock trades below its 50-day and 200-day moving averages ($89.17 and $88.69) and exhibits significant insider selling.
What is Colgate-Palmolive's price target from Wall Street analysts?
The median price target for Colgate-Palmolive from 21 Wall Street analysts is $100, with a high of $110 and a low of $87. This implies an upside of 13.3% from the current price of $88.27.
How has Colgate-Palmolive performed in recent earnings reports?
Colgate-Palmolive has shown a positive trend in recent earnings, beating EPS estimates in the last two reported quarters. For the quarter to June 2026, EPS was $0.99 against an estimate of $0.95, and for the quarter to March 2026, EPS was $0.65 against an estimate of $0.42.
What are the main risks facing Colgate-Palmolive?
Key risks include the stock's elevated valuation relative to its sector, significant insider selling exceeding $57 million, and current technical indicators showing the stock trading below its longer-term moving averages.
How does Colgate-Palmolive compare to its sector peers?
Colgate-Palmolive operates in the Consumer Defensive sector. While its P/E ratio (34.71) and P/S ratio (3.34) are higher than sector medians (24.2 and 2.2 respectively), its return on equity (267.37%) and profit margin (9.68%) significantly outperform sector averages (19.7% and N/A for profit margin).
What is the outlook for Colgate-Palmolive's revenue growth?
Revenue growth for Colgate-Palmolive is projected to be modest, with estimates around 3.00% for the next quarter and next year. The company's historical revenue growth has been 4.9%, aligning with the sector average.
What does the insider trading activity suggest for Colgate-Palmolive?
Insider activity indicates a 'Heavy Sell Signal,' with over $57 million in sales and no reported purchases. This suggests a lack of confidence from insiders regarding the stock's near-term performance.